Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amplicore
AddedFeb 16, 2024
UpdatedJun 18, 2026
Amplicore

Amplicore

Seed

Amplicore develops regenerative injectable therapeutics for musculoskeletal disorders.

HQ
Mason, OH, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to address unmet medical needs in musculoskeletal health, Amplicore develops regenerative injectable therapeutics. Their core focus is on treating degenerative conditions such as joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. By targeting the underlying causes of these conditions rather than just alleviating symptoms, Amplicore aims to restore mobility and improve the quality of life for patients.

Amplicore's notable achievements include the development of their flagship products, AM1101 for osteoarthritis and AM3101 for meniscal repair. The company has garnered attention from key investors in the biotech and healthcare sectors, which has enabled them to advance their research and clinical trials. Amplicore's innovative approach has positioned them as a promising player in the field of regenerative medicine, potentially transforming the treatment landscape for musculoskeletal disorders.

Amplicore - Similar Companies

Amplifica logo

Amplifica

amplificabio.com

Amplifier Therapeutics logo

Amplifier Therapeutics

amplifier-tx.com

Amphix Bio logo

Amphix Bio

amphixbio.com

Amplo Biotechnology logo

Amplo Biotechnology

CartilaGen logo

CartilaGen

cartilagen.com

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

ReLive logo

ReLive

relivebio.com

Biosplice Therapeutics logo

Biosplice Therapeutics

biosplice.com

DiscGenics logo

DiscGenics

discgenics.com

Amplified Sciences logo

Amplified Sciences

Cartilage logo

Cartilage

AmplifyBio logo

AmplifyBio

Inflammasome Therapeutics logo

Inflammasome Therapeutics

inflam.com

Sarcio logo

Sarcio

sarcioinc.com

Ampel Biosolutions logo

Ampel Biosolutions

Amplicore - Quick Facts

Who are Amplicore's competitors?

Companies similar to Amplicore include Amplifica, Amplifier Therapeutics, Amphix Bio and Amplo Biotechnology.

When was Amplicore founded?

Amplicore was founded in 2019.

Where is Amplicore's headquarters located?

Amplicore's headquarters is located in Mason, OH, US.

When was Amplicore's last funding round?

Amplicore's most recent funding round was for $4M (USD) in March 2021.

How much has Amplicore raised to-date?

As of Mar 25, 2021, Amplicore has raised a total of $4M (USD).

How many employees does Amplicore have?

Amplicore has 8 employees as of Feb 5, 2024.

Amplicore - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified